Scientific research now confirms that anxiety and insomnia can be caused by irregularities in the brain’s neurochemicals. Through its patented, frequency-related, advanced waveform that interacts with the deep centers of the midbrain, the Nexalin device supports the normalization of these chemicals.

Currently there is a mental health epidemic in the United States that originates with various mental health challenges that includes anxiety, insomnia, addiction, and early dementia. All these conditions originate in the health challenges of the brain. 

Nexalin’s tACS FDA-cleared treatment is a safe non-invasive, drug-free treatment that provides patients with a new opportunity related to mental health. The treatment can be administered in a quiet and calm room at a Nexalin providers office. The Nexalin medical device, produces a patented frequency waveform that transmits an undetectable electric frequency to stimulate a positive response in the patient’s brain that will resolve mental health issues. The technique is called “Transcranial Alternating Current Stimulation” (“tACS”).